Palantir Results Presentation Deck

O) 24 2020 BUSINESS UPDATE 000. 2021 PALANTIR TECHNOLOGIES INC. 29 Customer Updates ⁹3 / Government S/M 232,00 AVISA Signed a three-year, $44 million deal to expand our partnership with the FDA. → Expanding our work beyond the Oncology Center of Excellence and the Center for Drug Evaluation and Research ("CDER") Ensuring manufacturers comply with agency rules and regulations → Enhancing drug reviews to speed up time to market while maintaining the highest safety standards → READ MORE > 기기기기기기기 기기기기기 기기기기기기기기기기기기기 7777777777777 7777777777777 7777777777777 기기기기기기기기기기기

View entire presentation